Literature DB >> 19103765

Role of neutrophils in response to Bordetella pertussis infection in mice.

Charlotte Andreasen1, Nicholas H Carbonetti.   

Abstract

Pertussis is an acute respiratory disease caused by the bacterium Bordetella pertussis, for which humans are the only known reservoir. During infection, B. pertussis releases several toxins, including pertussis toxin (PT) and adenylate cyclase toxin (ACT), which have both been shown to play roles in promoting bacterial growth during early infection in a mouse model. Furthermore, in vitro and in vivo studies suggest that PT and ACT affect neutrophil chemotaxis and/or function, thereby altering the innate immune response. In this study we depleted animals of neutrophils to investigate whether neutrophils play a protective role during B. pertussis infection in mice. In addition, by infection with toxin-deficient strains, we investigated whether neutrophils are the main targets for PT and/or ACT activity in promoting bacterial growth. Surprisingly, we found no role for neutrophils during B. pertussis infection in naïve mice. However, in previously infected (immune) mice or in mice receiving immune serum, we observed a significant role for neutrophils during infection. Furthermore, in this immune mouse model our evidence indicates that neutrophils appear to be the main target cells for ACT, but not for PT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19103765      PMCID: PMC2643619          DOI: 10.1128/IAI.01150-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

Review 1.  Duration of immunity against pertussis after natural infection or vaccination.

Authors:  Aaron M Wendelboe; Annelies Van Rie; Stefania Salmaso; Janet A Englund
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

Review 2.  Interleukin-17 as an effector molecule of innate and acquired immunity against infections.

Authors:  Goro Matsuzaki; Masayuki Umemura
Journal:  Microbiol Immunol       Date:  2007       Impact factor: 1.955

3.  Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin.

Authors:  G J Spangrude; F Sacchi; H R Hill; D E Van Epps; R A Daynes
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

4.  Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteroides infection.

Authors:  T A Moore; M W Newstead; R M Strieter; B Mehrad; B L Beaman; T J Standiford
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

5.  EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis.

Authors:  Mattias Collin; Mikael D Svensson; Anders G Sjöholm; Jens C Jensenius; Ulf Sjöbring; Arne Olsén
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Role of gamma interferon in natural clearance of Bordetella pertussis infection.

Authors:  J Barbic; M F Leef; D L Burns; R D Shahin
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

7.  Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice.

Authors:  Charlotte Andreasen; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

8.  Role of C5 and recruited neutrophils in early clearance of nontypable Haemophilus influenzae from murine lungs.

Authors:  G B Toews; W C Vial; E J Hansen
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

9.  Effects of Bordetella pertussis infection on human respiratory epithelium in vivo and in vitro.

Authors:  R Wilson; R Read; M Thomas; A Rutman; K Harrison; V Lund; B Cookson; W Goldman; H Lambert; P Cole
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

10.  Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense.

Authors:  P Ye; F H Rodriguez; S Kanaly; K L Stocking; J Schurr; P Schwarzenberger; P Oliver; W Huang; P Zhang; J Zhang; J E Shellito; G J Bagby; S Nelson; K Charrier; J J Peschon; J K Kolls
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

View more
  28 in total

1.  Plasmacytoid dendritic cell-derived IFNα modulates Th17 differentiation during early Bordetella pertussis infection in mice.

Authors:  V Wu; A A Smith; H You; T A Nguyen; R Ferguson; M Taylor; J E Park; P Llontop; K R Youngman; T Abramson
Journal:  Mucosal Immunol       Date:  2015-10-14       Impact factor: 7.313

2.  Enhancement of Bordetella parapertussis infection by Bordetella pertussis in mixed infection of the respiratory tract.

Authors:  Zoë E V Worthington; Nico Van Rooijen; Nicholas H Carbonetti
Journal:  FEMS Immunol Med Microbiol       Date:  2011-07-29

Review 3.  Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools.

Authors:  Nicholas H Carbonetti
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

4.  Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans.

Authors:  Ang Lin; Danijela Apostolovic; Maja Jahnmatz; Frank Liang; Sebastian Ols; Teghesti Tecleab; Chenyan Wu; Marianne van Hage; Ken Solovay; Keith Rubin; Camille Locht; Rigmor Thorstensson; Marcel Thalen; Karin Loré
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

5.  Role of Major Toxin Virulence Factors in Pertussis Infection and Disease Pathogenesis.

Authors:  Karen Scanlon; Ciaran Skerry; Nicholas Carbonetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

6.  Cyclic AMP-mediated suppression of neutrophil extracellular trap formation and apoptosis by the Bordetella pertussis adenylate cyclase toxin.

Authors:  Joshua C Eby; Mary C Gray; Erik L Hewlett
Journal:  Infect Immun       Date:  2014-10-06       Impact factor: 3.441

7.  Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.

Authors:  Dylan T Boehm; Jesse M Hall; Ting Y Wong; Andrea M DiVenere; Emel Sen-Kilic; Justin R Bevere; Shelby D Bradford; Catherine B Blackwood; Cody M Elkins; Katherine A DeRoos; Mary C Gray; C Garret Cooper; Melinda E Varney; Jennifer A Maynard; Erik L Hewlett; Mariette Barbier; F Heath Damron
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

8.  Small mutations in Bordetella pertussis are associated with selective sweeps.

Authors:  Marjolein van Gent; Marieke J Bart; Han G J van der Heide; Kees J Heuvelman; Frits R Mooi
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

9.  Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice.

Authors:  Charlotte Andreasen; Daniel A Powell; Nicholas H Carbonetti
Journal:  PLoS One       Date:  2009-09-17       Impact factor: 3.240

10.  Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.

Authors:  Pádraig J Ross; Caroline E Sutton; Sarah Higgins; Aideen C Allen; Kevin Walsh; Alicja Misiak; Ed C Lavelle; Rachel M McLoughlin; Kingston H G Mills
Journal:  PLoS Pathog       Date:  2013-04-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.